CRDCs

Market Access

Under the VPAG agreement, £400 million is available under the VPAG Investment Fund. But what benefits will stay once funding goes away in 2029?

News

ITM's first attempt to score FDA approval for one of its radiopharma therapies has been knocked back by the agency.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.